What is happening with the newest cohort of tech and life science startups spun out of intellectual property invented at the University of Michigan? We’ve heard in recent times that the university has poured resources into programs for students interested in turning inventions and software into startups rather than taking a traditional job after graduation, but it seems spotty which majors and areas of the university are involved beyond computer science. We recently were introduced to several new startups navigating the entrepreneurial process straight out of college, and wanted to bring you the story of one small company and how it navigated through the maze of startup development from within the academic environment. It’s just one path to entrepreneurship in a growing tech and startup scene in Michigan, but one that is often hidden behind closed doors.
Health monitor biosensors are a topic in tech right now, but most of them are physical sensors, says Girish Kulkarni, founder of Arborsense. What if instead of using optics or sensors that measure blood pressure and flow through the skin, you could measure chemicals? We’ve been hearing for years now that graphene was supposed to take over the world, and maybe that world is finally arriving. Arborsense uses graphene electronic transdermal nano-sensors to test for chemicals and biomolecules through biomonitors. What does that mean? Here’s one example: Arborsense is partnering in clinical trials with Ann Arbor-based clinical psychiatrist Mark Ilgen at the Med School to use their graphene sensors to monitor drug addict patient alcohol blood levels through what molecules are excreted through the skin. That’s right. Instead of a breathalyzer one-time analysis of blood alcohol levels or other periodic tests for drug use, these graphene nano-sensors continuously monitor blood alcohol levels to track patient sobriety, health, and more.